Back to search

United Kingdom· GB-APID-37765311000001105

Rizmoic 200microgram tablets

A naldemedine product containing naldemedine, registered in United Kingdom by Viatris UK Healthcare Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC A06AH05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRizmoic 200microgram tabletsATCA06AH05REGISTER NO.GB-APID-3776531100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Naldemedine is registered in 14 of 19 countries.

Countries holding a registration under ATC A06AH05 (naldemedine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Naldemedine · ATC A06AH05

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of naldemedine costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Naldemedine · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

  • IT Italy$2.82
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Naldemedine
Manufacturer
Viatris UK Healthcare Ltd
Country
United Kingdom (GB)
ATC code
A06AH05
ATC class
Naldemedine
Defined daily dose
0.2 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    05060431940134
  • gtin
    5060431940479

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

174 interactions on record for naldemedine.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Naldemedine · interactions on record

174 records

  • 12 severe
  • 160 moderate
  • 2 minor

Most severe, free to view

  • RifampicinJ04AB02severe
  • RifapentineJ04AB05severe
  • MitotaneL01XX23severe
  • EnzalutamideL02BB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naldemedine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naldemedine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Rizmoic
  • Liechtenstein · Rizmoic
  • Norway · Rizmoic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/264f3535-e970-4183-84a0-4c661c96663e
GET /v1/drugs/264f3535-e970-4183-84a0-4c661c96663e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "37765311000001105",
  "desc": "Rizmoic 200microgram tablets (Viatris UK Healthcare Ltd)",
  "form": "Oral tablet",
  "vpid": "37828811000001100",
  "source": "dmd",
  "vtm_id": "776858005",
  "strength": "200 microgram",
  "substance": "Naldemedine",
  "ingredient": "Naldemedine tosylate",
  "supplier_code": "144301000001108"
}

See everything about naldemedine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.